|
Real-time Estimate
Cboe BZX
00:00:14 10/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 212.61 USD | +0.05% |
|
-4.30% | +21.08% |
| 11:36pm | Biogen Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 09:30 AM | |
| 09-09 | Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers | RE |
| Market Cap | 31.4B 27B 25.4B 23.18B 43.25B 2,977B 43.48B 301B 116B 1,521B 118B 115B 4,842B | P/E 2026 * |
36.7x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 36.33B 31.24B 29.39B 26.82B 50.05B 3,445B 50.31B 348B 135B 1,761B 136B 133B 5,603B | EV / Sales 2026 * |
3.48x | EV / Sales 2027 * | 3.17x |
| Free-Float |
85.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
Tradegate
| IDP | Real-time | |
Boerse Muenchen
| IDP | Real-time | |
Borsa Italiana
| 1BIIB | End-of-day quote | |
Mexican S.E.
| BIIB * | End-of-day quote | |
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
Deutsche Boerse AG
| IDP | Delayed | |
Xetra
| IDP | Delayed | |
Swiss Exchange
| BIIB | Delayed | |
Wiener Boerse
| BIIB | End-of-day quote | |
Börse Stuttgart
| IDP | Delayed | |
Santiago S.E.
| BIIB | End-of-day quote | |
Santiago S.E.
| BIIBCL | End-of-day quote | |
Swiss Exchange
| BIIB | Delayed |
Last Transcript : Biogen Inc.
| 1 day | +0.10% | ||
| 1 week | -4.30% | ||
| Current month | -1.65% | ||
| 1 month | +2.88% | ||
| 3 months | +7.02% | ||
| 6 months | +13.20% | ||
| Current year | +21.08% |
| 1 week | 209 | 225.8 | |
| 1 month | 201 | 225.8 | |
| Current year | 160.36 | 225.8 | |
| 1 year | 135.39 | 225.8 | |
| 3 years | 110.04 | 269.43 | |
| 5 years | 110.04 | 319.76 | |
| 10 years | 110.04 | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 4/8/26 | Sell | Director | -593 | 0.0004% | ||
| 9/6/26 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.05% | -4.30% | +48.39% | -17.70% | 31.4B | ||
| -0.93% | -5.60% | +44.53% | -3.50% | 80.91B | ||
| -0.78% | -0.64% | -19.76% | -36.79% | 60.46B | ||
| -2.06% | -8.80% | +462.09% | +30.00% | 56.02B | ||
| +0.83% | -4.47% | -8.40% | +30.44% | 49.63B | ||
| -1.11% | -7.21% | -2.15% | +148.24% | 45.88B | ||
| +1.56% | -1.71% | +47.93% | +96.60% | 25.22B | ||
| -2.00% | -3.35% | -2.29% | +177.79% | 22.25B | ||
| -3.02% | -2.59% | +60.23% | +99.82% | 16.59B | ||
| +0.90% | -7.14% | -23.99% | +726.73% | 14.38B | ||
| Average | -0.64% | -1.28% | +60.66% | +125.16% | 40.27B | |
| Weighted average by Cap. | -0.70% | -1.14% | +77.26% | +63.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.44B 8.98B 8.45B 7.71B 14.39B 990B 14.46B 100B 38.73B 506B 39.22B 38.36B 1,610B | 10.66B 9.16B 8.62B 7.87B 14.68B 1,010B 14.76B 102B 39.51B 516B 40.01B 39.14B 1,643B |
| Net income | 964M 829M 780M 711M 1.33B 91.38B 1.33B 9.24B 3.57B 46.7B 3.62B 3.54B 149B | 1.86B 1.6B 1.5B 1.37B 2.56B 176B 2.57B 17.78B 6.88B 89.91B 6.97B 6.82B 286B |
| Net Debt | 4.94B 4.24B 3.99B 3.64B 6.8B 468B 6.84B 47.31B 18.31B 239B 18.54B 18.13B 761B | 2.42B 2.08B 1.96B 1.79B 3.33B 229B 3.35B 23.19B 8.97B 117B 9.09B 8.89B 373B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | US$213.04 | +0.25% | 167,028 |
| 08/09/26 | US$212.50 | -3.77% | 617,829 |
| 04/09/26 | US$220.83 | -1.64% | 465,108 |
| 03/09/26 | US$224.51 | +0.83% | 550,745 |
| 02/09/26 | US$222.67 | +3.07% | 1,268,282 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions

















